Breakdown | Jun 2024 | Jun 2023 | Jun 2022 | Jun 2021 | Jun 2020 |
---|---|---|---|---|---|
Income Statement | |||||
Total Revenue | 15.72M | 12.09M | 13.36M | 49.93M | 28.41M |
Gross Profit | 11.36M | -5.16M | 9.75M | 40.27M | 12.77M |
EBITDA | -3.49M | -10.55M | -14.00M | 17.15M | 7.03M |
Net Income | -3.13M | -8.13M | -11.28M | 11.39M | 5.92M |
Balance Sheet | |||||
Total Assets | 26.05M | 28.98M | 38.36M | 50.72M | 49.80M |
Cash, Cash Equivalents and Short-Term Investments | 9.76M | 12.16M | 24.30M | 38.24M | 31.00M |
Total Debt | 3.45M | 4.00M | 4.13M | 4.38M | 2.40M |
Total Liabilities | 6.95M | 7.02M | 8.60M | 9.99M | 10.40M |
Stockholders Equity | 19.10M | 21.96M | 29.75M | 40.73M | 39.40M |
Cash Flow | |||||
Free Cash Flow | -1.76M | -11.97M | -13.60M | 11.73M | 4.31M |
Operating Cash Flow | -1.73M | -11.96M | -13.00M | 13.46M | 4.71M |
Investing Cash Flow | 2.00M | 7.06M | -628.00K | -14.18M | -1.94M |
Financing Cash Flow | -637.10K | -211.49K | -357.95K | 16.19M | 2.17M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
57 Neutral | £4.81B | 6.73 | -62.36% | 5.45% | 34.03% | 6.31% | |
51 Neutral | AU$48.53M | ― | -7.59% | ― | 28.89% | 72.95% | |
― | $54.07M | ― | -51.08% | ― | ― | ― | |
48 Neutral | AU$148.80M | ― | -58.61% | ― | ― | -74.88% | |
44 Neutral | AU$32.69M | ― | -135.33% | ― | -27.58% | 33.69% | |
41 Neutral | AU$113.36M | ― | -35.20% | ― | 4.68% | -155.42% | |
39 Underperform | AU$12.37M | ― | -98.08% | ― | -7.44% | 30.34% |
CleanSpace Holdings Limited reported a 26% increase in revenue for FY25, reaching $19.7 million, driven by strong sales in Europe, North America, and the APAC regions. The company’s focus on industrial markets and strategic expansion, including new sales staff and distribution agreements, has bolstered its market presence. CleanSpace’s innovative respirators continue to gain recognition, and the company is exploring new applications to expand growth opportunities.
CleanSpace Holdings Limited has received a $940,854 cash rebate from the Australian Federal Government’s R&D Tax Incentive Program for the financial year ending June 2024. This funding will support the company’s ongoing product research and development efforts in the Powered Air Purifying Respirator market, reinforcing its commitment to innovation and leadership in providing advanced respiratory protection solutions for industrial markets.
CleanSpace Holdings Ltd. has announced the quotation of 79,866 ordinary fully paid securities on the Australian Securities Exchange (ASX), effective May 30, 2025. This move is part of the company’s strategy to enhance liquidity and broaden its investor base, potentially strengthening its market position and offering more opportunities for stakeholders.